Levy Howard

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Levy Howard's trades of Gyre Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned purchase
Price
436.50
Quantity 94,791 -29.8%
Value US$2,137,578
Transaction date
Planned purchase
Price
189.43
Quantity 78,186 +33.4%
Value US$2,249,081
Transaction date
Purchase
Price
4.05
Quantity 2,500 +inf%
Value US$10,132
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-08-11 2021-08-09
PP Planned purchase
94,791 -29.8%
436.50
US$2,137,578 		94,791 -29.8% 436.50 US$2,137,578
2021-02-22 2021-02-09
PP Planned purchase
78,186 +33.4%
189.43
US$2,249,081 		78,186 +33.4% 189.43 US$2,249,081
2020-08-12 2020-08-10
PP Planned purchase
36,282 +33.6%
430.09
US$621,274 		36,282 +33.6% 430.09 US$621,274
2020-03-17 2020-03-16
B Purchase
2,500 +inf%
4.05
US$10,132 		2,500 +inf% 4.05 US$10,132